Cash from Operations (Annual) Chart

View Cash from Operations (Annual) for MGTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (Annual) Chart
Start Trial

Historical Cash from Operations (Annual) Data

View and export this data back to 2016. Start Trial.
Date Value
December 31, 2025 -46.36M
December 31, 2024 -104.50M
December 31, 2023 -105.36M
December 31, 2022 -73.10M
December 31, 2021 -10.53M
Date Value
December 31, 2020 -63.97M
December 31, 2019 20.04M
December 31, 2018 -58.89M
December 31, 2017 -18.06M
December 31, 2016 -14.37M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Annual) Range, Past 5 Years

View Cash from Operations (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Annual) Benchmarks

View Cash from Operations (Annual) Benchmarks
Start Trial
Xencor, Inc. -135.12M
UroGen Pharma Ltd. -162.44M
Ironwood Pharmaceuticals, Inc. 127.04M
Viking Therapeutics, Inc. -278.68M
IDEAYA Biosciences, Inc. -71.10M